This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
On April 22–25, 2015, the United States Pharmacopeial Convention (USP) will convene a meeting of its member organizations in Washington, DC.
Meeting every five years, USP’s member delegates represent more than 450 organizations that play a key role in upholding USP’s mission to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.
Highlighted topics and speakers at the convention will include:
Panel Discussion on Biologics
Thursday, April 23, 2015
9:45–11:15 a.m.
- Dr. Alfred Sandrock, Chief Medical Officer and Group Senior Vice President, Biogen Idec, Inc.
- Dr. Mark McCamish, Global Head of Biopharmaceutical and Oncology Injectable Development, Sandoz
- Dr. Karen Midthun, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
- Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
- Dr. Tina Morris, Global Leader, Biological Standards, U. S. Pharmacopeial Convention
- Dr. David Wood, Coordinator, Technologies Standards and Norms Team, Medicines and Health Products Department, World Health Organization
Invited Remarks
Friday, April 24, 2015
9:00–10:30 a.m.
- Mr. Howard Sklamberg, Deputy Commissioner for Global Regulatory Operations and Policy, U.S. Food and Drug Administration
- Dr. Tom Menighan, Chief Executive Officer, American Pharmacists Association
- Dr. Robert Wah, President, American Medical Association
- Mr. Ralph Neas, President and Chief Executive Officer, Generic Pharmaceutical Association
- Mr. John Castellani, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America
Panel Discussion on Global Health
Friday, April 24, 2015
2:00–3:15 p.m.
- Dr. Alexandra Graham, Co-founder and Vice President, LaGray, Inc.
- Ms. Maeve Magner, Supply Chain Expert and Independent Advisor
- Dr. Margareth Ndomondo-Sigonda, Pharmaceutical Coordinator African Union–New Partnership for Africa’s Development Planning and Coordinating Agency
- Ms. Kelly Willis, Senior Vice President, Global Public Health, U.S. Pharmacopeial Convention
>> For more information about the meeting, click here
